Evaxion Biotech AS (EVAX)
0.89
-0.02
(-2.73%)
USD |
NASDAQ |
Jan 08, 16:00
0.95
+0.06
(+6.74%)
After-Hours: 20:00
Evaxion Biotech Cash and Short Term Investments (Quarterly): 4.576M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Novo Nordisk AS | 11.22B |
Ascendis Pharma AS | 698.64M |
DBV Technologies SA | 46.44M |
Cellectis SA | 260.89M |
Adaptimmune Therapeutics PLC | 186.09M |